-
Job Opening: Health Scientist Administrator at NIDA Center for the CTN
The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is seeking candidates for Health Scientist Administrator (Program Officer GS-12/13/14) positions. The incumbents will provide scientific leadership and collaborate with NIDA Clinical Trials Network (CTN) investigators in the conception, design, development, conduct, and monitoring of clinical trials and other research studies, as well as guidance and assistance in the dissemination of research findings. Desired qualifications for candidates include expertise in behavioral, pharmacological, or integrated therapies for substance use/substance use disorders, experience in the management of clinical trials, and expertise in data science and implementation science. Expertise in increasing access to substance use disorder medication treatment through collaboration with pharmacies, expertise in Stimulant Use Disorder pharmacology and treatment, and expertise in polysubstance use are of particular interest. Essential skills include excellent interpersonal and communication skills, including the ability to work with diverse groups of researchers and community partners, and demonstrated scientific leadership and management skills. For additional information or to express interest in a position, please contact Dr. Kristen Huntley at huntleyk@mail.nih.gov and send your resume/CV. Applicants should apply to a National Institutes of Health (NIH) Global Recruitment announcement through USAjobs.gov. Please prepare to apply to the upcoming Health Scientist Administrator Global announcement for GS-12/13/14 (Program Officer), which will be open May 15-24, 2023. Applicants to previous global recruitment announcements for Health Scientist Administrators/Program Officers or Physicians/Medical Officers will also be considered.
-
News from the New England Consortium Node
NIDA News Release Buprenorphine initiation in the ER found safe and effective for individuals with OUD who use fentanyl. NIDA News, March 30, 2023. Referencing findings: D’Onofrio G, Hawk KF, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108. doi:10.1001/jamanetworkopen.2023.6108 New Publication Kropp FB, Smid MC, Lofwall MR, Wachman EM, Martin PR, Murphy SM, Wilder CM, Winhusen TJ. Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study. J Subst Use Addict Treat. 2023 Apr 4;149:209030. doi: 10.1016/j.josat.2023.209030. Epub ahead of print. PMID: 37023858. Posted April 17, 2023
-
New in the Library: March & April 2023
March-April 2023 Here are the newest items added to the Library in March and April 2023: Collaborative Care Programs for Pregnant and Postpartum Individuals with Opioid Use Disorder: Organizational Characteristics of Sites Participating in the NIDA CTN0080 MOMs Study. Kropp FB, et al. Journal of Substance Use and Addiction Treatment 2023;149:209030. CTN-0080 Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A Stepped Wedge Hybrid Type 1 Effectiveness-Implementation Study. Greiner MG, et al. Contemporary Clinical Trials 2023 (in press). CTN-0097 Optimizing Recruitment and Retention in Substance Use Disorder Research in Emergency Departments. Worth L, et al. West J Emerg Med 2023 (in press). CTN-0047 Repurposing Ketamine to Treat Cocaine Use Disorder: Integration of Artificial Intelligence-Based Prediction, Expert Evaluation, Clinical Corroboration, and Mechanism of Action Analyses. Gao X, et al. Addiction 2023 (in press). CTN-0114 Differential Symptom Weighting in Estimating Empirical Thresholds for Underlying PTSD Severity: Toward a “Platinum” Standard for Diagnosis? Morgan-Lopez A, et al. Int J Methods Psychiatr Res 2023;31963. CTN-0015 Estimating the Impact of Stimulant Use on Initiation of Buprenorphine and Extended-Release Naltrexone in Two Clinical Trials and Real-World Populations. Cook RR, et al. Addict Sci Clin Pract 2023;18:11. CTN-0051, CTN-0067 CTN Webinar: Research 101: Introduction to Clinical Trials: The Basics. Kim M & Vasquez M. Produced by the National Drug Abuse Treatment Clinical Trials Network’s Clinical Coordinating Center, March 3, 2023. Risk of Experiencing an Overdose Event for Patients Undergoing Treatment with Medication for Opioid Use Disorder. Brandt L, et al. Am J Psychiatry 2023 (in…
-
News from the Western States Node
CTN Western States Node investigators Dan Hartung and Elizabeth Waddell recently published findings from their CDC-funded project, Reducing Overdose After Release from Incarceration (PI: Waddell) that demonstrate risk of fatal and non-fatal opioid overdose risk is 10x greater among Oregon adults releasing from prison than in the state’s general population. Risk is even higher among women, those with documented substance use disorder and mental health treatment needs, and in the two weeks post release. Read the article in JSAT here. These findings are already driving policy discussions in Oregon and were covered in local media, emphasizing the need to start treatment prior to release and to allocate resources for more intentional release planning that connects adults in custody to community treatment. Check out the news reports here: Posted April 5, 2023
-
Webinar: The Greater Intermountain Node (GIN): Where We Were, Where We Are, and Where We Will Be (April 18, 12pm MT)
Presenter: Adam J. Gordon, MD, MPH, FACP, DFASAMApril 18, 2023 | 12:00-1:00 PM MST In this presentation, Dr. Gordon will describe the origination, present status, and future opportunities of the CTN Greater Intermountain Node (GIN). He will describe the mission and aims of GIN, as well as the three studies originating from the Node and six studies hosted by it. Dr. Gordon will emphasize the remarkable research and clinical collaboration across the University of Utah campus and greater Intermountain area. He will also discuss the robust mentored training of the GIN and look forward to how the GIN will evolve in the future. Connection information: Zoom ID: 931 8327 3330, passcode: parleys Posted April 3, 2023
-
CTN Youth SIG Webinar: Getting Evidence-Based Treatments to Youth and Families Who are Involved in the Juvenile Legal System (May 19, 11am ET)
The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: Getting Evidence-Based Treatments to Youth and Families Who are Involved in the Juvenile Legal System Ashli J. Sheidow, PhD, Senior Research Scientist, Oregon Social Learning CenterFriday, May 19th, 2023 (11:00 a.m.–12:00 p.m. ET) Dr. Sheidow’s services research examines methods and tools for getting substance use interventions to youth with juvenile legal system involvement. She will present lessons learned, with a focus on a task-shifting study with juvenile probation officers delivering contingency management treatment to youth and their parents/caregivers. The presentation will include insights into training and support for different providers, as well as lessons learned about services research design and methods. About the presenter Dr. Sheidow is a Senior Research Scientist in the Oregon Social Learning Center. She conducts research on treatments and services for adolescents and emerging adults who have substance use problems and legal system involvement. She also studies effective implementation of evidence-based practices by improving training supports and task-shifting in low-resourced environments, as well as recovery support services and community-engaged research with and by people who have lived experience in recovery and the legal system. Join Zoom MeetingZoom Meeting ID: 910 5122 3250Passcode: 609671Phone one-tap:US: +13017158592,,91051223250#,,,,*609671# or +13126266799,,91051223250#,,,,*609671 Posted April 3, 2023
